Conference icon

Conference

PROTECT-1 Study Demonstrated Efficacy of the Intestine-Specific Chemokine Receptor Antagonist CCX282-B (Traficet-EN) in Treatment of Patients with Moderate to Severe Crohn's Disease

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Experimental Medicine Division, Clinical Medicine
Johnson, D More by this author
Schall, TJ More by this author
Volume:
136
Issue:
5
Pages:
A65-A65
Publication date:
2009-05-05
ISSN:
0016-5085
URN:
uuid:f365a72e-1653-43af-b270-3f9f2ffccb6e
Source identifiers:
66869
Local pid:
pubs:66869

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP